Trpm2 Channel Inhibition
Trpm2 Channel Inhibition - Related Videos
05:31
A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
0 Views •
Cited by 7 •
2012
A real-time screening procedure for identifying drugs that interact with G protein-gated inward rectifier K+ (GIRK) channels is described. The assay utilizes membrane potential-sensitive fluorescent dyes to measure GIRK channel activity. This technique is adaptable for use on a number of cell lines.
16:00
Fabrication of the Thermoplastic Microfluidic Channels
0 Views •
2008
Here we demonstrate how to fabricate thermoplastic microfluidic chips using hot embossing and heat sealing. Then we demonstrate how to use in situ light directed surface grafting and polymerization through the sealed chip to form the composite solid phase columns.
10:07
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
0 Views •
Cited by 20 •
2013
Methods for developing and validating a quantitative fluorescence assay for measuring the activity of inward rectifier potassium (Kir) channels for high-throughput compound screening is presented.
01:30
Enzyme Inhibition
0 Views •
2025
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure. Competitive inhibitors occupy the active site of enzymes, making them unable to accommodate the substrate. However, sufficiently high...
00:46
Feedback Inhibition
0 Views •
2019
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell! Since enzymes help control the rate of reactions, their activity is regulated so that appropriate amounts of starting materials, intermediate metabolites, and products are maintained in the cell. Excessive build-up or depletion of...
FAQs
These signals reinforce channel opening rather than acting as isolated triggers. Intracellular ADP-ribose and reactive oxygen species promote activation, while calcium contributes to calcium-dependent activation. Once open, the channel permits additional sodium and calcium entry, creating a signaling pathway through which oxidative stress can amplify intracellular ionic changes in neurons or immune cells.
Blocking or suppressing the channel limits the sodium and calcium influx associated with its opening. Reduced calcium entry may lessen calcium overload, a process examined in relation to neuronal death and ischemic brain injury. This makes inhibition useful for testing whether TRPM2 links oxidative stress to downstream damage rather than merely accompanying those events.
Pharmacological blockers inhibit channel activity through an applied compound, whereas genetic suppression reduces the channel through an alteration in its expression or availability. Using these complementary strategies can help determine whether observed effects depend on TRPM2 itself or on the experimental blocking approach. Both are used to investigate the channel’s contribution to neuronal and immune-cell signaling.
The main processes include calcium overload, neuronal death, microglial activation, neuroinflammation, and damage associated with ischemic brain injury. These endpoints connect channel activity with both neuronal responses and immune-cell signaling in the nervous system. Examining them helps clarify how oxidative-stress-driven signals may influence tissue injury and neurodegenerative disease mechanisms.
A study can apply a pharmacological blocker or use genetic suppression, then examine changes in the channel-associated current or downstream cellular outcomes. Measurements may focus on sodium and calcium influx, calcium overload, neuronal survival, microglial activation, or inflammatory responses. Comparing inhibited conditions with corresponding noninhibited conditions helps identify effects associated with TRPM2 activity.
It is especially relevant when oxidative stress, calcium dysregulation, immune-cell activation, or tissue injury are central features of the question. Investigators can use inhibition to explore ischemic brain injury, neuroinflammation, neuronal death, and possible mechanisms of neurodegenerative disease. The approach may also inform efforts to develop therapies aimed at limiting oxidative-stress-driven damage.
These studies can indicate whether TRPM2 activity contributes functionally to injury-related signaling rather than simply correlating with oxidative stress. Changes in calcium overload, neuronal death, microglial activation, or neuroinflammation after inhibition provide evidence about the channel’s role in those processes. Such findings may help identify mechanisms that could be targeted to reduce oxidative-stress-driven damage.